Showing results (191-200 of 418) with videos related to

Sort By:
Pageof 42
Rheumatology (Oxford, England)|August 5, 2008
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitisG Simonini, M E Zannin, R Caputo, et al.
Radiology|October 1, 1992
Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imagingM C Dulce, G H Mostbeck, M O'Sullivan, et al.
Springerplus|September 22, 2016
The molecular characterization by SSRs reveals a new South Italian kinship and the origin of the cultivar Uva di TroiaC Bergamini, R Perniola, M F Cardone, et al.
Journal of Computer Assisted Tomography|January 1, 1994
Enhancement of thoracic masses using nonionic MR contrast agentsN Kanth, M Dulce, M O'Sullivan, et al.
Nephron|January 1, 1983
Cutaneous manifestations in renal transplant recipientsP L Bencini, G Montagnino, A De Vecchi, et al.
Dermatology (Basel, Switzerland)|January 1, 1995
The various clinical patterns of xanthoma disseminatum. Considerations on seven cases and review of the literatureR Caputo, S Veraldi, R Grimalt, et al.
Journal of the American Academy of Dermatology|November 1, 1988
Cutaneous manifestations of tetrachlorodibenzo-p-dioxin in children and adolescents. Follow-up 10 years after the Seveso, Italy, accidentR Caputo, M Monti, E Ermacora, et al.
International Journal of Cancer|March 4, 2000
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase AF Ciardiello, R Caputo, G Pomatico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growthG Tortora, R Caputo, G Pomatico, et al.
International Journal of Cancer|November 10, 2000
A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancerG Tortora, R Caputo, V Damiano, et al.
Pageof 42